BREAKING
KVH Industries Inc (KVHI) Reports Q4 Earnings 9 hours ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 9 hours ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 9 hours ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 10 hours ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 10 hours ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 10 hours ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 10 hours ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 11 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 11 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 12 hours ago KVH Industries Inc (KVHI) Reports Q4 Earnings 9 hours ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 9 hours ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 9 hours ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 10 hours ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 10 hours ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 10 hours ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 10 hours ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 11 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 11 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 12 hours ago
ADVERTISEMENT
Analysis

La-Z-Boy Incorporated Reports Q3 Fiscal 2026 Results; Revenue Up 4%, EPS at $0.52

$LZB February 18, 2026 2 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results
NYSE
$LZB · Earnings

La-Z-Boy Incorporated reported results for the third quarter of Fiscal 2026 (period ended January 24, 2026).

Current Status Overview

La-Z-Boy Incorporated reported results for the third quarter of Fiscal 2026 (period ended January 24, 2026). Consolidated sales increased 4% year-over-year to $541.6 million compared to $521.8 million in the prior-year quarter. GAAP operating income declined 15% to $29.8 million from $35.2 million, while GAAP operating margin decreased to 5.5% from 6.7%. Net income attributable to La-Z-Boy Incorporated fell 24% to $21.7 million from $28.4 million a year earlier. Diluted earnings per share were $0.52 compared to $0.68 in the prior-year period.

Share Price Performance

La-Z-Boy trades on the NYSE under the ticker LZB. The company did not disclose share price performance within the earnings release. Diluted weighted average shares outstanding decreased to 41.5 million from 42.1 million in the prior year quarter. The company resumed more normalized share repurchases during the quarter, buying back $14 million of stock. A quarterly cash dividend of $0.242 per share was declared.

Revenue Performance

Quarterly consolidated revenue totaled $541.6 million, up 4% year-over-year. Retail segment delivered sales increased 11% to $252 million, supported by new and acquired stores. Wholesale segment sales rose 1% to $366.6 million. Corporate and Other segment sales declined to $39.1 million from $40.7 million. For the first nine months of Fiscal 2026, revenue totaled $1.56 billion, up 1% from $1.54 billion in the prior-year period.

Market Analysis

Retail written sales increased 11% year-over-year, while written same-store sales declined 4%. Wholesale growth marked the seventh consecutive quarter of expansion in the core North America La-Z-Boy wholesale business. Joybird written sales decreased 13%, reflecting volatility in that consumer segment. Approximately 90% of upholstered products are produced in North America, reflecting the company’s vertically integrated model.

Analyst Commentary

No analyst commentary reported.

ADVERTISEMENT

Mergers & Acquisitions

The company completed integration of a 15-store acquisition in the Southeast U.S. region. Subsequent to quarter end, La-Z-Boy completed the sale of its Kincaid upholstery business and signed a letter of intent to sell its wholesale casegoods businesses. The company also announced the planned closure of its U.K. manufacturing facility by fiscal year end.

Outlook

For the fourth quarter of Fiscal 2026, the company expects sales in the range of $560 million to $580 million. Adjusted operating margin is expected to range between 7.5% and 9.0%. Management cited a cautious view on the macroeconomic backdrop and the short-term impact of adverse weather events.

ADVERTISEMENT
Tags: #LZB